← All trials
NCT03214250
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 21, 2017
- Primary completion
- Jul 1, 2022
- Completion date
- Sep 1, 2022
- First posted
- —
- Last posted
- —
- Enrollment
- 105
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- The Parker InstituteLead sponsor
- Apexigen, Inc.Collaborator
- Cancer Research InstituteCollaborator
- The Parker InstituteStudy director
- The Parker InstituteOfficial
- Bristol-Myers SquibbCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.